Martin Brenner - Jun 22, 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Stock symbol
IBIO
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/27/2023, 08:12 AM
Previous filing
Jun 22, 2023
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Disposed to Issuer $0 -75.8K -29.92% $0.00 178K Jun 22, 2023 Direct F1
transaction IBIO Common Stock Award $0 +75.8K +42.7% $0.00 253K Jun 26, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 75,833 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 75,833 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan") that expired prior to vesting.
F2 Consists of 75,833 shares of the Company's common stock, represented by 75,833 RSUs granted under the Company's 2020 Plan. Each RSU represents a contingent right to receive one share of Common Stock. The 75,833 RSUs vest pro rata over a seven-month period, such vesting to terminate if Dr. Brenner is no longer the Company's Chief Executive Officer

Remarks:

Chief Executive Officer and Chief Scientific Officer